Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluate the Safety and Efficacy of HL-1186 Tablet for Postoperative Analgesia in Orthopedic Surgery
Sponsor: Shanghai Huilun Pharmaceutical Co., Ltd.
Summary
This clinical trial is a multiple-center, randomized, double-blind, placebo- and active-controlled parallel-group Phase II/III clinical trial, to evaluate the efficacy and safety of HL-1186 Tablets for Postoperative Analgesia in Orthopedic Surgery.
Official title: A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled Parallel-Group Phase II/III Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablets for Postoperative Analgesia in Orthopedic Surgery
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
330
Start Date
2026-05-09
Completion Date
2026-12
Last Updated
2026-07-13
Healthy Volunteers
No
Conditions
Interventions
HL-1186
HL-1186 tablet for oral administration.
HL-1186 placebo
HL-1186 placebo tablet for oral administration.
Oxycodone-Acetaminophen
Oxycodone-Acetaminophen for oral adminstration
Oxycodone-Acetaminophen Matching Placebo
Oxycodone-Acetaminophen Matching Placebo for oral adminstration
Locations (1)
The Third Xiangya Hospital of Central South University, Changsha, Hunan
Changsha, Hunan, China